Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | PD173955 |
Synonyms | |
Therapy Description |
PD173955 is a tyrosine kinase inhibitor of Src and Bcr-Abl, which can result in anti-mitotic activity, induce apoptosis, and inhibit cell growth (PMID: 12154026, PMID: 10626805, PMID: 31620229). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PD173955 | BCR-ABL Inhibitor 31 SRC Inhibitor 31 | PD173955 is a tyrosine kinase inhibitor of Src and Bcr-Abl, which can result in anti-mitotic activity, induce apoptosis, and inhibit cell growth (PMID: 12154026, PMID: 10626805, PMID: 31620229). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|